Potential role of tocotrienols in the treatment and prevention of breast cancer

BioFactors

Volumn 40, Issue 1, 2014, Pages 49-58

  Sylvester, Paul W ^a   Akl, Mohamed R ^a   Malaviya, Abhita ^a   Parajuli, Parash ^a   Ananthula, Suryatheja ^a   Tiwari, Roshan V ^a   Ayoub, Nehad M ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

Apoptosis; Breast cancer; Combination chemotherapy; Signal transduction; Tocotrienols

Indexed keywords

APOPTOSIS; BREAST CANCER; COMBINATION CHEMOTHERAPY; SIGNAL TRANSDUCTION; TOCOTRIENOLS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL PROLIFERATION; DRUG SYNERGISM; FEMALE; HUMANS; TOCOTRIENOLS;

EID: 84894098395     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1116     Document Type: Review

References (50)

1. Sylvester, P. W., Wali, V. B., Bachawal, S. V., Shirode, A. B., Ayoub, N. M., et al. (2011) Tocotrienol combination therapy results in synergistic anticancer response. Front. Biosci. 17, 3183-3195.
2. Ong, A. S. (1993) Natural sources of tocotrienols. In Vitamin E in Health and Disease. (Packer, L., Fuchs, J., eds.). pp. 3-8, Marcel Dekker, New York
3. Behery, F. A., Elnagar, A. Y., Akl, M. R., Wali, V. B., Abuasal, B., et al. (2010) Redox-silent tocotrienol esters as breast cancer proliferation and migration inhibitors. Bioorg. Med. Chem. 18, 8066-8075.
4. Elnagar, A. Y., Wali, V. B., Sylvester, P. W., and El Sayed, K. A. (2010) Design and preliminary structure-activity relationship of redox-silent semisynthetic tocotrienol analogues as inhibitors for breast cancer proliferation and invasion. Bioorg. Med. Chem. 18, 755-768.
5. Sylvester, P. W., Ip, C., and Ip, M. M. (1986) Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats. Cancer Res. 46, 763-769.
6. Nesaretnam, K., Khor, H. T., Ganeson, J., Chong, Y. H., Sundram, K., et al. (1992) The effects of vitamin e tocotrienols from palm oil on chemically induced mammary carcingenesis in female rats. Nutr. Res. 12, 879-892.
7. Shah, S., Gapor, A., and Sylvester, P. W. (2003) Role of caspase-8 activation in mediating vitamin E-induced apoptosis in murine mammary cancer cells. Nutr. Cancer. 45, 236-246.
8. McIntyre, B. S., Briski, K. P., Gapor, A., and Sylvester, P. W. (2000) Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proc. Soc. Exp. Biol. Med. 224, 292-301.
9. McIntyre, B. S., Briski, K. P., Tirmenstein, M. A., Fariss, M. W., Gapor, A., et al. (2000) Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells. Lipids 35, 171-180.
10. Pierpaoli, E., Viola, V., Pilolli, F., Piroddi, M., Galli, F., et al. (2010) Gamma- and delta-tocotrienols exert a more potent anticancer effect than alpha-tocopheryl succinate on breast cancer cell lines irrespective of HER-2/Neu expression. Life Sci. 86, 668-675.
11. Sylvester, P. W., McIntyre, B. S., Gapor, A., and Briski, K. P. (2001) Vitamin e inhibition of normal mammary epithelial cell growth is associated with a reduction in protein kinase c(alpha) activation. Cell Prolif. 34, 347-357.
12. Normanno, N., De Luca, A., Bianco, C., Strizzi, L., Mancino, M., et al. (2006) Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366, 2-16.
13. Birkenfeld, H. P., McIntyre, B. S., Briski, K. P., and Sylvester, P. W. (1996) Role of protein kinase c in modulating epidermal growth factor- and phorbol ester-induced mammary epithelial cell growth in vitro. Exp Cell Res. 223, 183-191.
14. Sylvester, P. W., Nachnani, A., Shah, S., and Briski, K. P. (2002) Role of GTP-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells. Asia Pac. J. Clin. Nutr. 11, S452-S459.
15. Ahn, K. S., Sethi, G., Krishnan, K., and Aggarwal, B. B. (2007) Gamma-tocotrienol inhibits nuclear factor-kappa-b signaling pathway through inhibition of receptor-interacting protein and Tak1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. J. Biol. Chem. 282, 809-820.
16. Samant, G. V. and Sylvester, P. W. (2006) Gamma-tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells. Cell Prolif. 39, 563-574.
17. Bachawal, S. V., Wali, V. B., and Sylvester, P. W. (2010) Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses STAT and Akt signaling in murine mammary tumor cells. Anticancer Res. 30, 429-437.
18. Bachawal, S. V., Wali, V. B., and Sylvester, P. W. (2010) Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells. Biomed. Chromatogr. Cancer 10, 84.
19. Ayoub, N. M., Bachawal, S. V., and Sylvester, P. W. (2011) Gamma-tocotrienol inhibits HGF-dependent mitogenesis and Met activation in highly malignant mammary tumour cells. Cell Prolif. 44, 516-526.
20. Samant, G. V., Wali, V. B., and Sylvester, P. W. (2009) Anti-proliferative effects of gamma-tocotrienol on mammary tumour cells are associated with suppression of cell cycle progression. Cell Prolif. 43, 77-83.
21. Schmitz, I., Kirchhoff, S., and Krammer, P. H. (2000) Regulation of death receptor-mediated apoptosis pathways. Int. J. Biochem. Cell Biol. 32, 1123-1136.
22. Igney, F. H. and Krammer, P. H. (2002) Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2, 277-288.
23. Xu, C., Bailly-Maitre, B., and Reed, J. C. (2005) Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115, 2656-2664.
24. Tabas, I. and Ron, D. (2011) Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 13, 184-190.
25. Shah, S. J. and Sylvester, P. W. (2005) Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappa-b activity. Exp. Biol. Med. 230, 235-241.
26. Shah, S. and Sylvester, P. W. (2004) Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells. Exp. Biol. Med. 229, 745-755.
27. Shah, S. J. and Sylvester, P. W. (2005) Tocotrienol-induced cytotoxicity is unrelated to mitochondrial stress apoptotic signaling in neoplastic mammary epithelial cells. Biochem. Cell Biol. 83, 86-95.
28. Viola, V., Ciffolilli, S., Legnaioli, S., Piroddi, M., Betti, M., et al. Mitochondrial-dependent anticancer activity of delta-tocotrienol and its synthetic derivatives in HER-2/neu overexpressing breast adenocarcinoma cells. Biofactors. DOI: 10.1002/biof.1089, in press.
29. Park, S. K., Sanders, B. G., and Kline, K. (2010) Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling. Breast Cancer Res. Treat. 124, 361-375.
30. Wali, V. B., Bachawal, S. V., and Sylvester, P. W. (2009) Endoplasmic reticulum stress mediates gamma-tocotrienol-induced apoptosis in mammary tumor cells. Apoptosis 14, 1366-1377.
31. Gopalan, A., Yu, W., Jiang, Q., Jang, Y., Sanders, B. G., et al. (2012) Involvement of de novo ceramide synthesis in gamma-tocopherol and gamma-tocotrienol-induced apoptosis in human breast cancer cells. Mol. Nutr. Food Res. 56, 1803-1811.
32. Guthrie, N., Gapor, A., Chambers, A. F., and Carroll, K. K. (1997) Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. J. Nutr. 127, 544S-548S.
33. Hsieh, T. C. and Wu, J. M. (2008) Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells. Int. J. Oncol. 33, 851-859.
34. Geho, D. H., Bandle, R. W., Clair, T., and Liotta, L. A. (2005) Physiological mechanisms of tumor-cell invasion and migration. Physiology 20, 194-200.
35. Goldstein, J. L. and Brown, M. S. (1990) Regulation of the mevalonate pathway. Nature 343, 425-430.
36. Thibault, A., Samid, D., Tompkins, A. C., Figg, W. D., Cooper, M. R., et al. (1996) Phase i study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer. Clin Cancer Res. 2, 483-491.
37. Parker, R. A., Pearce, B. C., Clark, R. W., Gordon, D. A., and Wright, J. J. (1993) Tocotrienols regulate cholesterol production in mammalian cells by post- transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. J. Biol. Chem. 268, 11230-11238.
38. Wali, V. B. and Sylvester, P. W. (2007) Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells. Lipids. 42, 1113-1123.
39. Wali, V. B., Bachawal, S. V., and Sylvester, P. W. (2009) Suppression in mevalonate synthesis mediates antitumor effects of combined statin and gamma-tocotrienol treatment. Lipids 44, 925-934.
40. Wali, V. B., Bachawal, S. V., and Sylvester, P. W. (2009) Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1. Exp. Biol. Med. 234, 639-650.
41. zWang, D. and Dubois, R. N. (2006) Prostaglandins and cancer. Gut 55, 115-122.
42. Laible, B. (2005) Cox-2 inhibitors and cardiovascular toxicity: a class effect? S D J Med. 58, 93-94.
43. Shirode, A. B. and Sylvester, P. W. (2010) Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling. Biomed. Pharmacother. 64, 327-332.
44. Shirode, A. B. and Sylvester, P.W. (2011) Mechanisms mediating the synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment. J. Bioanal. Biomed. 3, 001-007.doi.10.4172/1948-593X.1000036.
45. Akl, M. R., Ayoub, N. M., and Sylvester, P. W. (2012) Mechanisms mediating the synergistic anticancer effects of combined gamma-tocotrienol and sesamin treatment. Planta Med. 78, 1731-1739.
46. Wang, X., Southard, R. C., and Kilgore, M. W. (2004) The increased expression of peroxisome proliferator-activated receptor-gamma1 in human breast cancer is mediated by selective promoter usage. Cancer Res. 64, 5592-5596.
47. Tachibana, K., Yamasaki, D., Ishimoto, K., and Doi, T. (2008) The role of PPARs in cancer. PPAR Res. 2008, 102737.
48. Saez, E., Rosenfeld, J., Livolsi, A., Olson, P., Lombardo, E., et al. (2004) PPAR gamma signaling exacerbates mammary gland tumor development. Genes Dev. 18, 528-540.
49. Fang, F., Kang, Z., and Wong, C. (2010) Vitamin E tocotrienols improve insulin sensitivity through activating peroxisome proliferator-activated receptors. Mol. Nutr. Food Res. 54, 345-352.
50. Malaviya, A. and Sylvester, P. W. (2013) Mechanisms mediating the effects of gamma-tocotrienol when used in combination with PPARgamma agonists or antagonists on MCF-7 and MDA-MB-231 breast cancer cells. Int. J. Breast Cancer 2013, 101705.